AI could spare thousands from unnecessary prostate biopsies
NCT ID NCT07614256
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether an artificial intelligence (AI) model can accurately predict which prostate cancers are aggressive and need treatment. Researchers will combine MRI and ultrasound images with tissue samples from 3,000 men. The goal is to reduce unnecessary biopsies and overdiagnosis of slow-growing cancers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICALLY SIGNIFICANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Liuzhou People's Hospital Affiliated to Guangxi Medical University
RECRUITINGLiuzhou, Guangxi, 545006, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A sharper eye on prostate cancer return: PSMA PET vs. MRI
- AI may help spot dangerous prostate cancer and spare men from needless biopsies
- Blood test may spot prostate cancer without a needle
- Which biopsy route catches more aggressive prostate cancers?
- AI reads scans to spot prostate cancer, spare unnecessary biopsies
- Extra numbing shot may ease pain of prostate biopsy